Nantahala Capital Management, LLC Portfolio Holdings

Nantahala Capital Management, LLC

  • $2.22 Billion
  • Q1 2025

Nantahala Capital Management, LLC has filed its 13F form on May 15, 2025 for Q1 2025 where it was disclosed a total value porftolio of $2.22 Billion distributed in 145 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Hilton Grand Vacations Inc. with a value of $74.3M, Establishment Labs Holdings Inc. with a value of $72.4M, Evolus, Inc. with a value of $43.9M, Bancorp, Inc. with a value of $43.8M, and Bioventus Inc. with a value of $37.7M.

Examining the 13F form we can see an increase of $230M in the current position value, from $1.99B to 2.22B.

Nantahala Capital Management, LLC is based out at New Canaan, CT

Below you can find more details about Nantahala Capital Management, LLC portfolio as well as his latest detailed transactions.

Portfolio value $2.22 Billion
ETFs: $1.13 Billion
Healthcare: $523 Million
Consumer Cyclical: $253 Million
Communication Services: $88.9 Million
Financial Services: $55.5 Million
Consumer Defensive: $51.7 Million
Real Estate: $43.9 Million
Industrials: $43.3 Million
Other: $31.3 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$13.5M
$4.62 Million 0.21% of portfolio
3,184,947
Q1 2025 Added 11.17%
$40.2M
$4.73 Million 0.21% of portfolio
3,877,965
Q1 2025 Added 5.39%
$89.9M
$4.46 Million 0.2% of portfolio
3,258,048
Q1 2025 Added 2.78%
$242M
$4.2 Million 0.19% of portfolio
629,749
Q1 2025 New
$43.1M
$3.95 Million 0.18% of portfolio
3,036,325
Q4 2024 Added 494.11%
$478M
$4.09 Million 0.18% of portfolio
2,987,983
Q1 2025 Added 6.55%
$962M
$3.91 Million 0.18% of portfolio
1,716,593
Q1 2025 New
$253M
$3.84 Million 0.17% of portfolio
312,094
Q1 2025 Reduced 44.47%
$193M
$3.75 Million 0.17% of portfolio
1,291,395
Q1 2025 Reduced 54.81%
$678M
$3.84 Million 0.17% of portfolio
2,000,000
Q1 2025 New
$47M
$3.87 Million 0.17% of portfolio
1,141,237
Q1 2025 Reduced 0.58%
$97.3M
$3.58 Million 0.16% of portfolio
669,530
Q1 2025 Reduced 0.81%
$423M
$3.61 Million 0.16% of portfolio
345,062
Q1 2025 New
$63.6M
$3.52 Million 0.16% of portfolio
914,618
Q1 2025 Reduced 0.04%
$152M
$3.3 Million 0.15% of portfolio
2,374,027
Q1 2025 Reduced 0.11%
$446M
$3.39 Million 0.15% of portfolio
200,000
Q1 2025 New
$336M
$3.21 Million 0.14% of portfolio
593,091
Q1 2025 Reduced 1.15%
$20.2M
$3.09 Million 0.14% of portfolio
3,157,895
Q1 2025 New
$206M
$2.94 Million 0.13% of portfolio
1,042,427
Q1 2025 Reduced 0.69%
$87.7M
$2.99 Million 0.13% of portfolio
368,182
Q1 2025 Reduced 0.11%
$108M
$2.62 Million 0.12% of portfolio
995,438
Q1 2025 Reduced 0.46%
$25.7M
$2.67 Million 0.12% of portfolio
1,921,088
Q1 2025 Reduced 32.92%
$6.61B
$2.47 Million 0.11% of portfolio
98,879
Q1 2025 Reduced 1.12%
$188M
$1.68 Million 0.08% of portfolio
2,477,312
Q1 2025 Added 16.4%
$658M
$1.81 Million 0.08% of portfolio
200,000
Q1 2025 New
$193M
$1.49 Million 0.07% of portfolio
530,713
Q1 2025 Added 99.06%
$37.6M
$1.56 Million 0.07% of portfolio
594,661
Q1 2025 Reduced 0.38%
$79M
$1.07 Million 0.05% of portfolio
487,778
Q1 2025 Reduced 0.45%
$2.39B
$1.08 Million 0.05% of portfolio
148,052
Q1 2025 Reduced 90.38%
$16.8M
$1.03 Million 0.05% of portfolio
1,692,303
Q1 2025 Reduced 30.78%
$10.2M
$1.18 Million 0.05% of portfolio
1,935,484
Q2 2024 New
$0
$925,000 0.04% of portfolio
495,041
Q1 2025 Reduced 0.99%
$151M
$809,000 0.04% of portfolio
20,427
Q1 2025 New
$980M
$863,000 0.04% of portfolio
100,000
Q1 2025 New
$20.2M
$872,000 0.04% of portfolio
660,688
Q1 2025 Reduced 0.2%
$980M
$825,000 0.04% of portfolio
650,000
Q1 2025 New
$44.4M
$751,000 0.03% of portfolio
185,452
Q1 2025 Reduced 66.35%
$65.8M
$498,000 0.02% of portfolio
57,030
Q1 2025 Added 94.55%
$40.9M
$140,000 0.01% of portfolio
94,541
Q4 2024 Reduced 25.18%
$114M
$219,000 0.01% of portfolio
61,186
Q1 2025 Reduced 1.5%
$166M
$211,000 0.01% of portfolio
460,850
Q1 2025 Reduced 93.02%
$1.41B
$289,000 0.01% of portfolio
25,401
Q1 2025 Reduced 0.9%
$37.1M
$55,000 0.0% of portfolio
15,046
Q4 2024 Reduced 25.23%
Tourmaline Bio Inc
-
$0 0.0% of portfolio
-
Q1 2025 Reduced 0.77%
Palvella Therapeutics Inc Ne
-
$0 0.0% of portfolio
-
Q4 2024 New
Onkure Therapeutics Inc
-
$0 0.0% of portfolio
-
Q1 2025 Reduced 1.04%
Theratechnologies Inc
-
$0 0.0% of portfolio
-
Q1 2025 Reduced 9.68%
Grace Therapeutics Inc
-
$0 0.0% of portfolio
-
Q1 2025 New
Evoke Pharma Inc
-
$0 0.0% of portfolio
-
Q1 2025 Reduced 0.03%

Summary

  • Portfolio
  • No. of Stocks 145
  • Current Value $2.22 Billion
  • Prior Value $1.99 Billion
  • Filing
  • Period Q1 2025
  • Filing Date May 15, 2025
  • Form Type 13F-HR
  • Activity in Q1 2025
  • New Purchases 18 stocks
  • Additional Purchases 38 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 57 stocks
Track This Portfolio

Track Nantahala Capital Management, LLC Portfolio

Follow Nantahala Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nantahala Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nantahala Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email